A diabetes, heart failure, and kidney disease medication is the first of its kind to significantly reduce both heart attacks and strokes Post author:Annie Holland Post published:February 18, 2025 Post category:News Feed Post comments:0 Comments New research shows sotagliflozin is the only drug in its class to demonstrate these results. You Might Also Like Powerful new software platform could reshape biomedical research by making data analysis more accessible April 3, 2025 Identifying a proliferating repairman for tissue in damaged lungs December 10, 2024 Hidden DNA mechanisms of rare genetic diseases uncovered June 22, 2024 Leave a Reply Cancel replyCommentEnter your name or username to comment Enter your email address to comment Enter your website URL (optional) Save my name, email, and website in this browser for the next time I comment.
Powerful new software platform could reshape biomedical research by making data analysis more accessible April 3, 2025